Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58)
This is vastly more dilute than topical formulations, but isolated cells in culture have direct peptide access without any barrier to penetration
The World Anti-Doping Agency (WADA) classifies BPC 157 as a non-approved substance, prohibiting its use in sports
Side effect tolerance Temporary digestive symptoms can occur as the body adjusts to treatment
US$ 22.86
US$ 23.55
US$ 23.40
